Skip to main content

Day: December 10, 2021

Nordic American Tankers Ltd (NYSE: NAT) – Board Members buy Shares in NAT

Friday, December 10, 2021Dear Shareholders and Investors,    We are pleased to report to you that Board Members have recently increased the number of NAT shares they own. Board member Alexander Hansson has since November 26 bought 150,000 shares. His private holding is 1,135,000 shares. Board member Jim Kelly has 210,000 shares in NAT. Board member Doug Penick joined the Board July 19, 2021. He has 175,000 shares. The Hansson family is the largest private shareholder, holding marginally below 5 million shares. I applaud the strong support by the NAT Board.   Sincerely, Herbjorn HanssonFounder, Chairman & CEO Nordic American Tankers Ltd.                                                           www.nat.bm      CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Matters discussed in this press release may constitute forward-looking...

Continue reading

Sonoco Provides Strategic Overview and Issues 2022 Financial Guidance

Strategy Targets $1 Billion in Annual EBITDA in Five Years 2021 Base EPS Expected to be at the Top End of Previous Guidance2022 Base EPS Estimated to be $3.85 to $3.95HARTSVILLE, S.C., Dec. 10, 2021 (GLOBE NEWSWIRE) — Sonoco (NYSE: SON), one of the largest diversified global packaging companies, today provided an overview of its five-year strategic plan and 2022 financial guidance during a virtual meeting with investors. Featured presenters at the meeting included: Howard Coker, President and Chief Executive Officer; Rodger Fuller, Executive Vice President; Julie Albrecht, Vice President and Chief Financial Officer; and Elizabeth Rhue, Staff Vice President of Sustainability. The presentation from today’s event is available on the Investor Relations section of Sonoco’s website at www.sonoco.com. Strategy Targets Annual EBITDA...

Continue reading

MamaMancini’s Secures $2 Million in Sales Through “Today’s Special Value” Promotion on QVC®

MamaMancini’s Product Named ‘Today’s Special Value’ on QVC, Promoted with Approximately 5 Hours of Airtime EAST RUTHERFORD, NJ, Dec. 10, 2021 (GLOBE NEWSWIRE) — MamaMancini’s Holdings, Inc. (NASDAQ: MMMB), a marketer of specialty pre-prepared, frozen and refrigerated food products, today announced that QVC® selected the Company’s 3-Cheese Beef and Turkey Meatballs in Italian Sauce as the network’s Today’s Special Value (TSV) promotion for December 8th, 2021 – airing a promotion with approximately 5 hours of airtime on several shows throughout the day. The promotion was extremely successful with MamaMancini’s sales over $800,000 for immediate delivery throughout the holidays. The airings, which launched at midnight, provided QVC customers the opportunity to purchase MamaMancini’s product throughout the day at special value-based...

Continue reading

iBio Announces Partial Adjournment of Annual Meeting to December 22

– Shareholders Presently Supporting Reverse Split and Authorized Share Proposals by a 2-to-1 Margin – BRYAN, Texas, Dec. 10, 2021 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced that its annual meeting of stockholders (the “Annual Meeting”) scheduled for and convened yesterday has been partially adjourned to December 22, 2021 at 9:00 a.m. Eastern Time. A quorum was present at yesterday’s Annual Meeting, and Proposals 1 (election of directors), 2 (appointment of auditors) and 3 (Say-on-Pay) put forth in the definitive proxy statement received the requisite votes for approval. The Company’s stockholders also approved Proposal 6 (adjournment...

Continue reading

DIRTT Reiterates commitment to engaging with shareholders in an appropriate forum

DIRTT responds to Activist’s December 9, 2021 “proposal” CALGARY, Alberta, Dec. 10, 2021 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT”, the “Company”, “we” or “us”) (Nasdaq: DRTT, TSX: DRT), an interior construction company that uses proprietary software to design, manufacture and install fully customizable environments, announced today that the committee of its independent directors (the “Special Committee”) tasked with reviewing and considering the requisition made by an activist investor, 22NW Fund, LP, (the “Activist”) has reiterated its commitment to being prepared to engage in discussions with the Activist to settle this unnecessary proxy fight. Since August 5, 2021, representatives of the Company have been in negotiations with Mr. Aron English (the principal of the Activist) regarding him joining the board...

Continue reading

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) Laser Focused on B2B iGaming Market

NEW YORK, Dec. 10, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Digitization Reshaped Ecommerce First, Now Moving to Online Gaming,” please visit: https://nnw.fm/KY9FT The early days of ecommerce can be traced back decades, sluggish until the 2000s, then accelerating rapidly over the last 10-plus years. Online gaming is on a similar trajectory. Analogous to what Amazon and Alibaba did for ecommerce, online gaming has deep roots that go back decades and now has entered a growth stage that many believe will chart...

Continue reading

Assure Holdings Announces Results of Annual General Meeting of Shareholders

DENVER, Dec. 10, 2021 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced that it held its virtual annual general meeting of shareholders (the “Meeting”) yesterday and that all matters submitted to the shareholders of the Company for approval as set out in the Company’s definitive proxy statement dated November 9, 2021 (the “Proxy Statement”), were approved by the requisite majority of votes cast at the Meeting, including:Electing all nominees to the board of directors of the Company, including Martin Burian, John Farlinger, Preston Parsons, Christopher Rumana, Steven Summer and John Flood. Re-appointing Baker Tilly US (formerly, Squar Milner, LLP) as auditors of the Company for the ensuing year. Approving the...

Continue reading

Scottish bus operator Xplore Dundee orders 12 NFI electric double-deck buses

NFI – BYD ADL Enviro400EV electric double deck bus for Xplore DundeeNFI – BYD ADL Enviro400EV electric double deck bus for Xplore DundeeLARBERT, Scotland, Dec. 10, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, subsidiary Alexander Dennis Limited (“ADL”), today announced that the ADL and BYD electric vehicle partnership has supplied 12 British-built electric double deck buses to bus operator Xplore Dundee. These new vehicles will reduce greenhouse gas emissions and deliver cleaner, quieter, more sustainable mobility along one of Scotland’s most polluted streets. The ADL and BYD UK electric vehicle partnership is the UK’s leading electric bus producer. ADL is a subsidiary...

Continue reading

Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer

– ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data presented at San Antonio Breast Cancer Symposium – – ARV-471 is expected to enter two Phase 3 registrational clinical trials in 2022 – NEW HAVEN, Conn. and NEW YORK, Dec. 10, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced an update on Phase 1 dose escalation data of ARV-471, a novel PROTAC® estrogen receptor (ER) degrader, which is being co-developed for the treatment of patients with locally advanced or metastatic ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer (ER+/HER2-). These data were presented as a virtual spotlight poster session at the 2021 San Antonio Breast Cancer Symposium (SABCS) and showed:ARV-471 demonstrated...

Continue reading

Timbercreek Financial Announces Exercise of Over-Allotment Option in connection with Bought Deal Offering of Convertible Debentures

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Dec. 10, 2021 (GLOBE NEWSWIRE) — Timbercreek Financial Corp. (TSX: TF) (“Timbercreek Financial” or the “Company”) is pleased to announce that the underwriters of its bought deal offering of 5.00% convertible unsecured subordinated debentures of the Company due December 31, 2028 (the “Debentures”) have fully exercised their previously announced over-allotment option, resulting in the issuance by the Company of an additional $6.0 million aggregate principal amount of Debentures. The exercise of the over-allotment option brings the total aggregate principal amount of Debentures issued by the Company to $46.0 million. The Debentures are listed on the Toronto Stock Exchange under the symbol “TF.DB.E”. The syndicate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.